LRLouise Fremgaard Risnes

Louise Fremgaard Risnes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louise Fremgaard Risnes has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serology-based diagnosis of coeliac disease in secondary care: a single-centre study in Norway

    by Jostein H. Ibsen, Ane Kongsgaard, Michael Sovershaev, Stine R. Lund, Vemund Paulsen, Ole Darre-Næss, Kjetil Garborg, Christer Tønnesen, Lars Aabakken, Louise F. Risnes, et al.

    Coeliac disease (CeD) affects 1-2% of the western population. Diagnosis is based on serology and duodenal biopsy, but serology-based diagnosis in adults has been approved in Europe. To evaluate the diagnostic performance of IgA anti-transglutaminase 2 (IgA-TG2) and IgG anti-deamidated gliadin peptides (IgG-DGP), and their combinations, compared with biopsy in a real-world secondary care setting. Adult patients referred to secondary care endoscopy service at Oslo University Hospital for suspected CeD were invited to participate. CeD diagnosis followed European and Norwegian guidelines, requiring positive serology and mucosal damage. Among 312 evaluable patients, 215 were diagnosed with CeD between 2018 and 2024. Analysis of IgA-TG2 above threshold (>4 U/ml) showed 93% specificity and 94% sensitivity, while IgG-DGP (>20 U/ml) showed 88% specificity and 83% sensitivity. In ROC analyses, the AUC values were 0.98 and 0.95, respectively. Higher threshold (2x, 3x, 5x and 10x ULN) of IgA-TG2 increased specificity (99% to 100%) but lowered sensitivity (82% to 49%). Using IgG-DGP did not increase specificity but detected six missed CeD cases by IgA-TG2. Forty-two percent (n = 92) of cases could be diagnosed with a no-biopsy approach with 10x ULN IgA-TG2 at referral with 100% specificity. Serology correlates strongly with histological changes, supporting diagnosis without gastroscopy. A 10x ULN threshold shows excellent specificity at the expense of sensitivity, thus lower thresholds may be preferable due to diminishing gains in specificity. IgG-DGP serves as a valuable complementary marker, that improves sensitivity and helps identify patients with weak IgA-TG2 responses.

  • Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial

    by Louise F. Risnes, Margit Brottveit, Ida Robertsen, Jostein Ibsen, Lars Aabakken, Marie K. Johannesen, Stine R. Lund, Siv K. B. Furholm, Siv E. H. Isaksen, Anders Åsberg, et al.

    Coeliac disease is an autoimmune disorder driven by gluten and managed through a strict gluten‐free diet. We tested teriflunomide, a drug known for its ability to alter T‐cell activity, in a phase 2a trial of 15 patients with coeliac disease. Participants received teriflunomide or placebo including a loading dose, followed by a 3‐day oral gluten challenge to monitor T‐cell responses. The main aim was to observe attenuation of gluten‐specific T‐cell activation markers after gluten exposure. We found no significant differences in T‐cell activity between groups, concluding that teriflunomide is ineffective as a non‐dietary treatment for coeliac disease.


  • Open Access

    A predisposing effect of HLA class II genes in celiac disease by skewing the naïve CD4 + T-cell receptor repertoire

    by Ida Lindeman, Aengus Officer, Shiva Dahal-Koirala, Louise F. Risnes, Rebecka Hjort, Knut E. A. Lundin, Eivind Ness-Jensen, Corey T. Watson, Ludvig M. Sollid

    Polymorphisms of human leukocyte antigen (HLA) genes confer risks for many human diseases. For predisposing effects relating to T-cell receptor (TCR) recognition of peptide-HLA, the effect can be both selection of the TCR repertoire and preferential presentation of disease-driving epitopes. In celiac disease (CeD) HLA-DQ2.5 predisposes by presenting deamidated gluten peptides to CD4 + T cells that typically employ stereotyped TCRs. Here we analyzed whether genetic variants within the HLA and TR loci shape the naïve TCR repertoire. We sequenced the αβ TCR repertoires of naïve CD4 + T cells of 103 CeD subjects and 103 controls and performed gene usage quantitative trait loci analyses. The naïve CD4 + TCR repertoire was significantly affected by HLA and TRA and TRB polymorphisms. Individuals carrying the HLA-DQ2.5 allotype exhibited increased frequencies of TCR genes involved in stereotyped recognition of gluten epitopes thus demonstrating a disease-predisposing effect of HLA by selection of a disease-relevant TCR repertoire.

  • Open Access

    Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease

    by Louise F. Risnes, Henrik M. Reims, Ronan M. Doyle, Shuo-Wang Qiao, Ludvig M. Sollid, Knut E.A. Lundin, Asbjørn Christophersen


  • Open Access

    Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

    by Ida Lindeman, Lene S. Høydahl, Asbjørn Christophersen, Louise F. Risnes, Jørgen Jahnsen, Knut E. A. Lundin, Ludvig M. Sollid, Rasmus Iversen

    Autoantibodies against the enzyme transglutaminase 2 (TG2) are characteristic of celiac disease (CeD), and TG2-specific IgA plasma cells are abundant in gut biopsies of patients. We here describe the corresponding population of autoreactive B cells in blood. Circulating TG2-specific IgA cells were found in untreated patients on a gluten-containing diet but not in controls. They were clonally related to TG2-specific small intestinal plasma cells, and they expressed gut-homing molecules, indicating that they are plasma cell precursors. Unlike other IgA-switched cells, the TG2-specific cells were negative for CD27, placing them in the double negative (IgD-CD27-) category. They had a plasmablast or activated memory B-cell phenotype, and they harbored fewer variable region mutations than other IgA cells. Based on their similarity to naïve B cells, we propose that autoreactive IgA cells in CeD are generated mainly through chronic recruitment of naïve B cells via an extrafollicular response involving gluten-specific CD4+ T cells.


  • Contributors

    by Daniel Agardh, Julie Antvorskov, Federico Biagi, Margit Brottveit, Antonio Carroccio, Ashish Chauhan, Carolina Ciacci, Jette Frederiksen, Marios Hadjivassiliou, Kaisa Hervonen, et al.